CVE-2024-45983
Published: 26 September 2024
Summary
CVE-2024-45983 is a medium-severity CSRF (CWE-352) vulnerability in Kishan0725 Hospital Management System. Its CVSS base score is 6.3 (Medium).
Operationally, exploitation aligns with the MITRE ATT&CK technique Exploit Public-Facing Application (T1190); ranked at the 39.2th percentile by exploit likelihood (below the median); it is not currently listed in the CISA KEV catalog; a public proof-of-concept is referenced.
EU & UK References
- 🇪🇺 ENISA EUVD: EUVD-2024-41666
Vulnerability details
A Cross-Site Request Forgery (CSRF) vulnerability exists in kishan0725's Hospital Management System version 6.3.5. The vulnerability allows an attacker to craft a malicious HTML form that submits a request to delete a doctor record. By enticing an authenticated admin user…
more
to visit the specially crafted web page, the attacker can leverage the victim's browser to make unauthorized requests to the vulnerable endpoint, effectively allowing the attacker to perform actions on behalf of the admin without their consent.
- CWE(s)
Related Threats
MITRE ATT&CK Enterprise TechniquesAI
Why these techniques?
The CSRF vulnerability enables exploitation of a public-facing web application (Hospital Management System) to perform unauthorized actions, such as deleting doctor records, on behalf of an authenticated admin user tricked into visiting a malicious page.
Affected Assets
Mitigating Controls
Likely Mitigating Controls AI
Per-CVE control mapping for this CVE has not run yet; the list below is derived from the weakness types (CWEs) cited in the NVD entry.
Awareness training educates users on avoiding untrusted links and actions that can be exploited via CSRF.
Requiring user re-entry of credentials for sensitive actions prevents automated forgery of requests without active user participation.
Security testing regimens explicitly include checks for missing or ineffective anti-CSRF protections in web applications.
Detects anomalous request patterns consistent with cross-site request forgery.